Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

US Patent 9957238 · Granted May 1, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

3,5-diamino-6-chloro-N-(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)etho2023
Monothiol mucolytic agents2021
3,5-diamino-6-chloro-N—(N-(4-(4-(2-(hexyl(2,3,4,5,6-pentahydroxyhexyl)amino)etho2020
Prodrugs of dithiol mucolytic agents2020
Dendrimer like amino amides possessing sodium channel blocker activity for the t2020
Methods of treatment2019
3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide c2019
Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compo2019
Sodium channel blockers2019
Chemically and metabolically stable dipeptide possessing potent sodium channel b2018
Monothiol mucolytic agents2018
Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking 2018